1. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening

   • Jie Li
   • Huawei Xu
   • Xianbao Zhan

   Original Article – Cancer Research 09 October 2019 Pages: 2637 - 2647

   

2. CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach

   • Vivek Anand
   • Madhuram Khandelwal
   • Alpana Sharma

   Original Article – Cancer Research 16 September 2019 Pages: 2649 - 2661

   

3. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer

   • Cuiling Zhou
   • Gang Che
   • Haiqing Ma

   Original Article – Cancer Research 20 September 2019 Pages: 2663 - 2674

   

4. Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells

   • Jelena Mihajlović
   • Laura A. M. Diehl
   • Joachim H. Clement

   Original Article – Cancer Research 17 September 2019 Pages: 2675 - 2687

   

5. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases

   • Florian Bösch
   • Rumyana Todorova
   • Jens Neumann

   Original Article – Cancer Research 20 September 2019 Pages: 2689 - 2697

   

6. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer

   • Nicole Golob-Schwarzl
   • Christina Wodlej
   • Johannes Haybaeck

   Original Article – Cancer Research Open access 04 October 2019 Pages: 2699 - 2711

   

7. A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer

   • Lele Liu
   • Xingguo Song
   • Xianrang Song

   Original Article – Cancer Research 24 September 2019 Pages: 2713 - 2723

   

8. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer

   • Sophie Baumgart
   • Pascal Meschkat
   • Kerstin Junker

   Original Article – Cancer Research 24 September 2019 Pages: 2725 - 2736

   

9. Outcome in serous ovarian cancer is not associated with LATS expression

   • Céline Montavon
   • Gregor R. Stricker
   • André Fedier

   Original Article – Cancer Research Open access 04 October 2019 Pages: 2737 - 2749

   

10. Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence

    • Yuyang Ze
    • Xiaowen Zhang
    • Yan Bi

    Review – Clinical Oncology 30 September 2019 Pages: 2751 - 2759

    

11. Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

    • Cyrill Wehling
    • Daniel Hornuss
    • Jan Pfeiffenberger

    Original Article – Clinical Oncology 19 August 2019 Pages: 2761 - 2769

    

12. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China

    • Bing Chen
    • Wenjie Xia
    • Feng Jiang

    Original Article – Clinical Oncology 19 August 2019 Pages: 2771 - 2777

    

13. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

    • Karin Melanie Cabanillas Stanchi
    • Manon Queudeville
    • Michaela Döring

    Original Article – Clinical Oncology 24 August 2019 Pages: 2779 - 2791

    

14. Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series

    • Wanpeng Li
    • Hanyu Lu
    • Dehui Wang

    Original Article – Clinical Oncology 23 August 2019 Pages: 2793 - 2802

    

15. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype

    • Irina Demina
    • Elena Zerkalenkova
    • Alexander M. Popov

    Original Article – Clinical Oncology 28 August 2019 Pages: 2803 - 2811

    

16. Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments

    • C. Ostheimer
    • C. Evers
    • Daniel Medenwald

    Original Article – Clinical Oncology 06 September 2019 Pages: 2813 - 2822

    

17. Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

    • Niels Smedegaard Andersen
    • Martin Bornhäuser
    • the CLL subcommittee, Chronic Malignancies Working Party

    Original Article – Clinical Oncology 29 August 2019 Pages: 2823 - 2834

    

18. 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes

    • Anja L. Gawlitza
    • Johanna Speith
    • Thomas Ernst

    Original Article – Clinical Oncology 10 September 2019 Pages: 2835 - 2843

    

19. Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial

    • Susanne Singer
    • Helge Danker
    • Julia Roick

    Original Article – Clinical Oncology 10 September 2019 Pages: 2845 - 2854

    

20. Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients

    • Karl R. Aigner
    • Sabine Gailhofer
    • Kornelia Aigner

    Original Article – Clinical Oncology Open access 10 September 2019 Pages: 2855 - 2862

    

21. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy

    • Sang Hun Song
    • Chang Hee Ye
    • Jong Jin Oh

    Original Article – Clinical Oncology 09 September 2019 Pages: 2863 - 2870

    

22. Impact of 9q deletions on the classification of patients with acute myeloid leukemia

    • Bettina Balk
    • Torsten Haferlach
    • Anna Stengel

    Letter to the Editors 29 March 2019 Pages: 2871 - 2874